Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference

Rhea-AI Summary

Genocea Biosciences (NASDAQ: GNCA) will have its CEO, Chip Clark, participate in a fireside chat at the B. Riley Securities’ Virtual Oncology Investor Conference. This event is scheduled for January 21, 2021, from 11:00 am to 11:30 am ET. Investors can access the live webcast on Genocea's website, where it will also be archived for approximately 90 days. Genocea focuses on developing personalized cancer immunotherapies using its ATLAS™ platform to optimize neoantigens and exclude immunosuppressive Inhibigens™.

CAMBRIDGE, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will participate in a fireside chat at B. Riley Securities’ Virtual Oncology Investor Conference on January 21, 2021 from 11:00 am – 11:30 am Eastern Time. A live webcast of the fireside chat will be available on the Genocea website at http://ir.genocea.com. This event will also remain archived on the Genocea website for approximately 90 days.

About Genocea Biosciences, Inc.
Genocea’s mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient’s T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood. To learn more, please visit www.genocea.com.

Investor Contact:
Dan Ferry
617-430-7576
daniel@lifesciadvisors.com

FAQ

When is Genocea Biosciences' fireside chat at the B. Riley Securities’ Virtual Oncology Investor Conference?

The fireside chat will take place on January 21, 2021, from 11:00 am to 11:30 am Eastern Time.

Who is participating in the fireside chat for Genocea Biosciences?

Chip Clark, the president and CEO of Genocea Biosciences, will participate in the event.

How can I access the webcast of the Genocea Biosciences fireside chat?

The live webcast can be accessed on the Genocea website and will be archived for 90 days.

What is the main focus of Genocea Biosciences?

Genocea Biosciences is focused on developing personalized cancer immunotherapies using its ATLAS™ platform.

What are the programs being advanced by Genocea Biosciences?

Genocea is advancing two ATLAS-enabled programs: GEN-009, a neoantigen vaccine, and GEN-011, a neoantigen-specific cell therapy.